LYMPHOMAP

Curated by Signal

Provider of AI-based platform for the diagnosis of cancer

Overview

Lymphomap is an AI-based platform for the diagnosis of cancer. It helps oncologists and pathologists with the diagnosis of Lymphoma, Leukemia, and Myeloma (blood cancers), as well as other kinds of cancers involving solid tumors. It combines data analysis techniques such as topological data analysis with a machine learning algorithm for identification and prediction of the tumor.

Key facts

Founded: 2021
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Health Technology

Business model

7 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

All Star Wellness
Provider of fitness and wellness programs for employees
Health TechnologyFort Lauderdale, United States
DoctorsForMe.AI
AI based doctor searching platform for cancer patients
Health TechnologySan Francisco, United States
DASH Analytics
Clinical decision making tool for healthcare professionals
Health TechnologyMemphis, United States

About LYMPHOMAP

What does LYMPHOMAP do?

Lymphomap is an AI-based platform for the diagnosis of cancer.

Where is LYMPHOMAP headquartered?

LYMPHOMAP is headquartered in New York City, United States.

When was LYMPHOMAP founded?

LYMPHOMAP was founded in 2021.

Which sector is LYMPHOMAP in?

LYMPHOMAP operates in Health Technology.

Who are LYMPHOMAP's competitors?

Companies similar to LYMPHOMAP include All Star Wellness, DoctorsForMe.AI, and DASH Analytics.